DK1446404T3 - Rosiglitazonedisylater og deres anvendelse som antidiabetika - Google Patents

Rosiglitazonedisylater og deres anvendelse som antidiabetika

Info

Publication number
DK1446404T3
DK1446404T3 DK02779713T DK02779713T DK1446404T3 DK 1446404 T3 DK1446404 T3 DK 1446404T3 DK 02779713 T DK02779713 T DK 02779713T DK 02779713 T DK02779713 T DK 02779713T DK 1446404 T3 DK1446404 T3 DK 1446404T3
Authority
DK
Denmark
Prior art keywords
disylates
antidiabetics
rosiglitazone
salt
ethanedisulfonicacid
Prior art date
Application number
DK02779713T
Other languages
Danish (da)
English (en)
Inventor
Tim Chien Ting Ho
Michael John Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0127932A external-priority patent/GB0127932D0/en
Priority claimed from GB0127933A external-priority patent/GB0127933D0/en
Priority claimed from GB0127931A external-priority patent/GB0127931D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1446404T3 publication Critical patent/DK1446404T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK02779713T 2001-11-21 2002-11-21 Rosiglitazonedisylater og deres anvendelse som antidiabetika DK1446404T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0127932A GB0127932D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127933A GB0127933D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127931A GB0127931D0 (en) 2001-11-21 2001-11-21 Novel compounds

Publications (1)

Publication Number Publication Date
DK1446404T3 true DK1446404T3 (da) 2006-10-09

Family

ID=27256332

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02779713T DK1446404T3 (da) 2001-11-21 2002-11-21 Rosiglitazonedisylater og deres anvendelse som antidiabetika

Country Status (12)

Country Link
US (1) US20050107440A1 (de)
EP (1) EP1446404B1 (de)
JP (1) JP2005515987A (de)
KR (1) KR20040062965A (de)
CN (1) CN1612874A (de)
AT (1) ATE329914T1 (de)
AU (1) AU2002343052A1 (de)
DE (1) DE60212434T2 (de)
DK (1) DK1446404T3 (de)
ES (1) ES2266593T3 (de)
PT (1) PT1446404E (de)
WO (1) WO2003045947A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003269483A1 (en) * 2003-09-10 2005-03-29 Biocon Limited Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
MX2008008213A (es) 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
MX2009006768A (es) * 2006-12-22 2009-08-31 Bellus Health Int Ltd Metodos, compuestos, y composiciones para tratar trastornos metabolicos y diabetes.
KR20110015254A (ko) * 2009-08-07 2011-02-15 한미홀딩스 주식회사 프라수그렐 디술폰산염 및 이의 결정
CN101758337B (zh) 2009-12-03 2012-02-15 湖南阿斯达生化科技有限公司 一种助焊剂用非卤素活性剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7609666L (sv) * 1975-09-12 1977-03-13 Roussel Uclaf Sett att framstella nya 5-aminometyltiazolderivat
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
ATE329914T1 (de) 2006-07-15
ES2266593T3 (es) 2007-03-01
DE60212434T2 (de) 2007-05-24
DE60212434D1 (de) 2006-07-27
EP1446404B1 (de) 2006-06-14
EP1446404A1 (de) 2004-08-18
CN1612874A (zh) 2005-05-04
JP2005515987A (ja) 2005-06-02
PT1446404E (pt) 2006-10-31
KR20040062965A (ko) 2004-07-09
AU2002343052A1 (en) 2003-06-10
US20050107440A1 (en) 2005-05-19
WO2003045947A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CY1105252T1 (el) Το υδροχλωρικο αλας της 5-[4-[2-(ν-μεθυλο-ν-(2-πυριδυλο)αμινο)-αιθοξυ]βενζυλο]θειαζολιδινο-2,4-διονης
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
DK1315721T3 (da) Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
BR0112983A (pt) Sais tartarato de derivado de tiazolidinodiona
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt